Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
NUNEZ, JR v. IMPAX LABORATORIES, INC. et al
Case Number:
3:16-cv-08420
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
February 23, 2017
Impax Investor Drops Suit Over Drug Price-Fixing Probe
A shareholder alleging generic-drug maker Impax Laboratories Inc. failed to disclose to investors a federal investigation over possibly collusive market activity has dropped his proposed class action in New Jersey federal court because a similar action is pending in California.
-
November 14, 2016
Impax Investor Says Drug Price-Fixing Probe Never Disclosed
Impax Laboratories Inc. was smacked Thursday with a shareholder suit in New Jersey federal court accusing the bioequivalent and generic drugmaker of failing to disclose to investors a U.S. Department of Justice investigation over possibly collusive market activity which has impacted the company's value.